PO.BCS01.02 · 生物信息与计算

骨肉瘤的单细胞RNA-seq分析揭示了跨部位和跨物种的保守及独特生态系统

Single cell RNA-seq analysis of osteosarcoma reveals conserved and distinct ecosystems across sites and species

海报缩略图:骨肉瘤的单细胞RNA-seq分析揭示了跨部位和跨物种的保守及独特生态系统
编号 1428 展板 22 时间 4/20 09:00–12:00 区域 Section 3 主讲 Yogesh Budhathoki
分会场 Application of Bioinformatics to Cancer Biology 2
查看 PDF 下载 PDF 🔒 查看 / 下载完整 PDF 需登录并开通下载套餐 · 查看套餐 / 开通 AACR 官方页面

作者与单位 Authors & Affiliations

Yogesh Budhathoki1, Matthew Cannon1, Troy A. Mceachron2, Anand G. Patel3, Matthew Gust1, Jaime F. Modiano4, Dylan T. Ammons5, Kathryn Cronise5, Daniel Regan5, Heather Gardner6, Ryan D. Roberts1

1Nationwide Children's Hospital, Columbus, OH,2National Cancer Institute, Bethesda, MD,3St. Jude Children's Research Hospital, Memphis, TN,4University of Minnesota, Minneapolis, MN,5Colorado State University, Fort Collins, CO,6Cummings School of Veterinary Medicine, Tufts University, North Grafton, MA

摘要 Abstract

中文摘要
骨肉瘤表现出深刻的异质性,长期以来一直阻碍着理解其机制和推进治疗进展的努力。为解开这一复杂性,我们汇编了迄今最大的跨物种单细胞转录组数据集,整合了来自人类患者、犬类患者、患者来源异种移植物和小鼠模型的775,441个细胞。据我们所知,该数据集代表了任何实体瘤中首次实现的多物种、多技术、多部位(原发和转移)单细胞数据协调,为在生物学和进化背景下探究肿瘤间和肿瘤内异质性提供了统一的框架。 通过这项工作,我们定义了跨肿瘤、跨物种和跨疾病部位保守的骨肉瘤肿瘤细胞亚群。这些亚群跨越了一个分化状态的连续谱,从静止的祖细胞样细胞到更分化的产基质型和炎症型表型,提示存在一个保守的发育层级。对基质区室的分析揭示了骨肉瘤中既有已确立的、也有此前未被认识的特征,包括在原发和肺转移部位均存在骨相关破骨细胞样巨噬细胞,以及在转移性肺病灶中炎症性和瘢痕相关巨噬细胞的富集,我们此前已将后者与转移进展相关联。 所得图谱为探索和发现提供了丰富且前所未有的资源。利用该资源,我们表征了发生在原发和转移部位的肿瘤-宿主相互作用,并跨物种进行了比较。该分析揭示了转移性肺病灶内数量惊人的基质来源信号,远超原发骨病灶中所鉴定的信号。例如,我们发现肿瘤来源的纤连蛋白与上皮细胞上的syndecans和整合素受体结合,诱导出一种与肺纤维化中所描述的极为相似的致病表型。利用空间转录组数据对这些相互作用的验证鉴定出支持特定肿瘤细胞亚群的独特邻域,且这些模式在样本间保守。 总体而言,这项工作建立了一个变革性的资源和概念框架,用于理解肿瘤异质性、进化和微环境重塑。它作为一个强大的平台,用于假设生成、模型保真度评估和治疗发现,指导下一代骨肉瘤生物学转化进展。
查看英文原文 English abstract
Osteosarcoma exhibits profound heterogeneity that has long challenged efforts to understand its mechanisms and advance therapeutic progress. To unravel this complexity, we compiled the largest cross-species single-cell transcriptomic dataset, integrating 775,441 cells from human patients, dog patients, patient-derived xenografts, and mouse models. To our knowledge, this dataset represents the first multi-species, multi-technology, and multi-site (primary and metastatic) harmonization of single-cell data for any solid tumor, enabling a unified framework for interrogating inter- and intra-tumor heterogeneity across biological and evolutionary contexts. Through this work, we define subpopulations of osteosarcoma tumor cells that are conserved across tumors, species, and disease sites. These subpopulations span a continuum of differentiation states, from quiescent progenitor-like cells to more differentiated matrix-producing and inflammatory phenotypes, suggesting a conserved developmental hierarchy. Analysis of the stromal compartment revealed both established and previously unappreciated features of osteosarcoma, including the presence of bone-associated osteoclast-like macrophages in both primary and lung metastatic sites and enrichment of inflammatory and scar-associated macrophages in metastatic lung lesions, which we have previously implicated in metastatic progression. The resulting atlas provides a rich and unprecedented resource for exploration and discovery. Using this resource, we characterized tumor-host interactions occurring in primary and metastatic sites and compared them across species. This analysis revealed a striking number of matrix-derived signals within metastatic lung lesions, far exceeding those identified in primary bone lesions. For example, we found that tumor-derived fibronectin engages syndecans and integrin receptors on epithelial cells, inducing a pathogenic phenotype remarkably similar to that described in pulmonary fibrosis. Validation of these interactions using spatial transcriptomic data identifies distinct neighborhoods that support specific tumor cell subpopulations, with patterns conserved across samples. Collectively, this work establishes a transformative resource and conceptual framework for understanding tumor heterogeneity, evolution, and microenvironmental remodeling. It serves as a powerful platform for hypothesis generation, model fidelity assessment, and therapeutic discovery, guiding the next generation of translational advances in osteosarcoma biology.
利益披露 Disclosure
Y. Budhathoki, None.. M. Cannon, None.. M. Gust, None.. D. T. Ammons, None.. K. Cronise, None.. H. Gardner, None.

← 返回 AACR 2026 检索